Abstract
Background
Esophageal squamous cell neoplasms (ESCNs) are common second primary tumors in patients with head and neck cancer. Image-enhanced endoscopy (IEE) with Lugol chromoendoscopy or magnifying narrow-band imaging both increase the detection of early ESCNs. No evidence-based ESCN surveillance program for head and neck cancer patients without a history of synchronous ESCNs exists. We aimed to evaluate the performance of an IEE surveillance program with magnifying narrow-band imaging endoscopy and Lugol chromoendoscopy.
Methods
From April 2016, we routinely used IEE with magnifying narrow-band imaging and Lugol chromoendoscopy to evaluate patients with head and neck cancer history. All patients who were negative for ESCNs at the first surveillance endoscopy and received at least 2 IEEs through December 2019 were included. Demographic profiles, clinical data, cancer characteristics, IEE results and pathology reports were analyzed.
Results
A total of 178 patients were included. Only 4 patients (2.2%) developed metachronous ESCNs during follow-up, all of whom received curative resection treatment. The interval for the development of metachronous ESCNs was 477 to 717 days. In multivariate Firth logistic regression and Kaplan‒Meier survival curve analysis, Lugol’s voiding lesion type C had an increased risk of esophageal cancer development (adjusted odds ratio = 15.71; 95% confidence interval, 1.33–185.87, p = 0.029). Eight patients died during the study period, and none of them had metachronous ESCNs.
Conclusions
IEE with magnifying narrow-band imaging and Lugol chromoendoscopy is an effective surveillance program in head and neck cancer patients without a history of ESCNs. Annual surveillance can timely detect early ESCNs with low ESCN-related mortality.
Similar content being viewed by others
Data availability
The data are not publicly available but are available from the corresponding author on reasonable request.
References
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49.
Chung CS, Liao LJ, Wu CY, et al. Endoscopic screening for second primary tumors of the esophagus among head and neck cancer patients. Front Oncol. 2022;12: 906125.
Erkal HS, Mendenhall WM, Amdur RJ, et al. Synchronous and metachronous squamous cell carcinomas of the head and neck mucosal sites. J Clin Oncol. 2001;19(5):1358–62.
Lee DH, Roh JL, Baek S, et al. Second cancer incidence, risk factor, and specific mortality in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg. 2013;149(4):579–86.
Wang WL, Lee CT, Lee YC, et al. Risk factors for developing synchronous esophageal neoplasia in patients with head and neck cancer. Head Neck. 2011;33(1):77–81.
Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.
Chen YH, Wang YK, Chuang YS, et al. Endoscopic surveillance for metachronous esophageal squamous cell neoplasms among head and neck cancer patients. Cancers (Basel). 2020;12(12):3832.
Chu PY, Chang SY, Huang JL, et al. Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. Am J Otolaryngol. 2010;31(3):168–74.
Liao LJ, Chou HW, Wang CT, et al. The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS ONE. 2013;8(4): e62116.
Lim H, Kim DH, Jung HY, et al. Clinical significance of early detection of esophageal cancer in patients with head and neck cancer. Gut Liver. 2015;9(2):159–65.
Njei B, McCarty TR, Birk JW. Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis. J Gastroenterol Hepatol. 2016;31(6):1141–6.
Wang Y, Shi J, Du L, et al. Health-related quality of life in patients with esophageal cancer or precancerous lesions assessed by EQ-5D: a multicenter cross-sectional study. Thorac Cancer. 2020;11(4):1076–89.
Liu Y, Dou L, Rao W, et al. The feasibility and safety of endoscopic submucosal dissection for circumferential superficial esophageal squamous cell neoplasms. J Clin Med. 2023;12(2):471.
Takubo K, Aida J, Sawabe M, et al. Early squamous cell carcinoma of the oesophagus: the Japanese viewpoint. Histopathology. 2007;51(6):733–42.
Chadwick G, Groene O, Hoare J, et al. A population-based, retrospective, cohort study of esophageal cancer missed at endoscopy. Endoscopy. 2014;46(7):553–60.
Huang YW, Wang YP, Lee TL, et al. Image-enhanced endoscopy for detection of second primary esophageal neoplasms in patients with hypopharyngeal cancer: prevalence, risk factors, and characteristics. J Chin Med Assoc. 2021;84(10):963–8.
Katada C, Yokoyama T, Yano T, et al. Alcohol consumption and multiple dysplastic lesions increase risk of squamous cell carcinoma in the esophagus, head, and neck. Gastroenterology. 2016;151(5):860–9 (e7).
Dawsey SM, Fleischer DE, Wang GQ, et al. Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian. China Cancer. 1998;83(2):220–31.
Nagami Y, Tominaga K, Machida H, et al. Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching. Am J Gastroenterol. 2014;109(6):845–54.
Muto M, Minashi K, Yano T, et al. Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol. 2010;28(9):1566–72.
Morita FH, Bernardo WM, Ide E, et al. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. BMC Cancer. 2017;17(1):54.
Gruner M, Denis A, Masliah C, et al. Narrow-band imaging versus Lugol chromoendoscopy for esophageal squamous cell cancer screening in normal endoscopic practice: randomized controlled trial. Endoscopy. 2021;53(7):674–82.
Petit T, Georges C, Jung GM, et al. Systematic esophageal endoscopy screening in patients previously treated for head and neck squamous-cell carcinoma. Ann Oncol. 2001;12(5):643–6.
Caudell JJ, Gillison ML, Maghami E, et al. NCCN Guidelines(R) insights: head and neck cancers, version 1.2022. J Natl Compr Canc Netw. 2022;20(3):224–34.
Machiels JP, Rene Leemans C, Golusinski W, et al. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31(11):1462–75.
Oyama T, Inoue H, Arima M, et al. Prediction of the invasion depth of superficial squamous cell carcinoma based on microvessel morphology: magnifying endoscopic classification of the Japan Esophageal Society. Esophagus. 2017;14(2):105–12.
Dixon MF. Gastrointestinal epithelial neoplasia: vienna revisited. Gut. 2002;51(1):130–1.
Lydiatt WM, Patel SG, O'Sullivan B, et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):122–37.
Rice TW, Patil DT, Blackstone EH. 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg. 2017;6(2):119–30.
Brinkman GL, Coates EO Jr. The effect of bronchitis, smoking, and occupation on ventilation. Am Rev Respir Dis. 1963;87:684–93.
Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80(1):27–38.
Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21(16):2409–19.
Puhr R, Heinze G, Nold M, et al. Firth’s logistic regression with rare events: accurate effect estimates and predictions? Stat Med. 2017;36(14):2302–17.
Fukuhara T, Hiyama T, Tanaka S, et al. Characteristics of esophageal squamous cell carcinomas and lugol-voiding lesions in patients with head and neck squamous cell carcinoma. J Clin Gastroenterol. 2010;44(2):e27-33.
Jarl J, Gerdtham UG. Time pattern of reduction in risk of oesophageal cancer following alcohol cessation–a meta-analysis. Addiction. 2012;107(7):1234–43.
Muto M, Katada C, Yokoyama T, et al. Field effect of alcohol, cigarette smoking, and their cessation on the development of multiple dysplastic lesions and squamous cell carcinoma: a long-term multicenter cohort study. Gastro Hep Advances. 2022;1(2):265–76.
Schena M, Battaglia AF, Munoz F. Esophageal cancer developed in a radiated field: can we reduce the risk of a poor prognosis cancer? J Thorac Dis. 2017;9(7):1767–71.
Micke O, Schafer U, Glashorster M, et al. Radiation-induced esophageal carcinoma 30 years after mediastinal irradiation: case report and review of the literature. Jpn J Clin Oncol. 1999;29(3):164–70.
Nobel TB, Barbetta A, Hsu M, et al. Outcomes of radiation-associated esophageal squamous cell carcinoma: the MSKCC experience. J Gastrointest Surg. 2019;23(1):11–22.
MRCOC Working. Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet. 2002;359(9319):1727–33.
Chen YH, Lu HI, Chien CY, et al. Efficacy of different chemotherapy regimens in patients with locally advanced synchronous esophageal and head/neck squamous cell carcinoma receiving curative concurrent chemoradiotherapy. J Clin Med. 2020;9(1):197.
Kuzuu K, Misawa N, Ashikari K, et al. Gastrointestinal cancer stage at diagnosis before and during the COVID-19 pandemic in Japan. JAMA Netw Open. 2021;4(9): e2126334.
Pandeya N, Williams G, Green AC, et al. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136(4):1215–24 (e1–2).
Northcote J, Livingston M. Accuracy of self-reported drinking: observational verification of ‘last occasion’ drink estimates of young adults. Alcohol Alcohol. 2011;46(6):709–13.
Acknowledgements
The study was supported by grants from the Ministry of Science and Technology, Taiwan (MOST 110-2628-B-075-009) and Taipei Veterans General Hospital (V112C-088). The funding sources had no role in any process of our study.
Funding
The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Author information
Authors and Affiliations
Contributions
Concept and design: YC YE, YP WANG, IF HSIN, PH CHEN, SK TAI, PY CHU, MC HOU, CL LU. Acquisition, analysis, or interpretation of data: YC YE, YP WANG, IF HSIN, PH CHEN, SK TAI, PY CHU, PS WU, TE CHANG. Drafting of the manuscript: YC YE, YP WANG, PS WU, TE CHANG, MC HOU, CL LU. Critical revision of the manuscript for important intellectual content: YP WANG, TE CHANG, SK TAI, PY CHU, MC HOU, CL LU. Statistical analysis: YC YE, YP WANG, IF HSIN, PH CHEN. Obtained funding: YP WANG. Administrative, technical, or material support: YP WANG, IF HSIN, PH CHEN. Supervision: YP WANG.
Corresponding author
Ethics declarations
Ethical Statement
This research study was conducted retrospectively from data obtained for clinical purposes. This study was approved by the Taipei Veterans General Hospital Institutional Review Board (IRB, 2022-12-005BC).
Conflict of interest
The authors have not disclosed any conflict of interests.
Consent to participate
Informed consent was waived by Taipei Veterans General Hospital Institutional Review Board.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ye, YC., Wang, YP., Chang, TE. et al. Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patients. Esophagus 21, 131–140 (2024). https://doi.org/10.1007/s10388-023-01039-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10388-023-01039-3